409
© The Editor(s) (if applicable) and The Author(s), under exclusive license
to Springer Nature Switzerland AG 2021
M. S. H. Akash et al. (eds.), Endocrine Disrupting Chemicals-induced
Metabolic Disorders and Treatment Strategies, Emerging Contaminants
and Associated Treatment Technologies,
https://doi.org/10.1007/978-3-030-45923-9_25
Chapter 25
Role of Nanoparticles in the Management
of Metabolic Disorders
Zoya Iqbal, Muhammad Ibrahim, and Ghulam Murtaza
Abstract Nanotechnology, a rapidly flourishing field has emerged as cutting-edge
technology in the twenty-first century indicating a promising future. Over the past
decades, explosive research efforts have resulted in the development and evaluation
of a plethora of nanoparticles for potential applications such as diagnosis and therapy. Hence playing a crucial role in research and development (R and D) and driving a revolution. NPs have garnered the interest of researchers due to their controlled
and sustained-release features, biocompatibility, and subcellular size as well as
extensively studied in pharmaceutical and medical fields. Since, the mode of fabrication plays a pivotal role; therefore, several techniques have been employed to
prepare the NPs of desired characteristics for a particular application, i.e. the properties of NPs can be optimized based on the preparation method. Thus, various
techniques have been employed to formulate NPs over the past two decades.
Keywords Nanoparticles · Diagnosis · Therapy · Sustained-release · Metabolic
diseases
Z. Iqbal
Department of Pharmacy, The University of Lahore, Lahore, Pakistan
M. Ibrahim
Department of Applied Chemistry, Government College University Faisalabad,
Faisalabad, Pakistan
G. Murtaza (*)
Department of Pharmacy, COMSATS University Islamabad, Lahore, Pakistan
Précédent

- 416/526

Suivant